3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Myelodysplastic Syndromes
2
Mycosis Fungoides
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Leukemia, Myeloid, Acute
2
Urinary Bladder Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Multiple Myeloma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, B-Cell
1
Immunoblastic Lymphadenopathy
1
Gliosarcoma
1
Glioblastoma
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Interventions
Temozolomide
6
Radiosurgery
6
pembrolizumab
4
Magnetic Resonance Spectroscopy
4
Bevacizumab
4
Specimen Handling
3
Nivolumab
3
abemaciclib
2
Watchful Waiting
2
Surveys and Questionnaires
2
Receptors, Interleukin-8B
2
Radiation
2
Mental Status and Dementia Tests
2
Memantine
2
Ipilimumab
2
Biopsy
2
vorasidenib
1
sotorasib
1
sapanisertib
1
ribociclib
1
pertuzumab
1
osimertinib
1
lenvatinib
1
fluciclovine F-18
1
entrectinib
1
encorafenib
1
elacestrant
1
brivaracetam
1
binimetinib
1
Valacyclovir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
Photons
×
30 days
×
Clear all
No trials found.